The merger was valued at $3.26 billion when it was pitched by Optum earlier in June. The agreement calls for the acquisition of Amedisys’ outstanding common stock in an all-cash transaction for $101 per share, according to a June 26 news release from Amedisys.
According to the release, the merger “unites two organizations dedicated to providing compassionate, value-based comprehensive care to patients and their families.”
Amedisys has about 18,000 employees in 522 care centers across 37 states and Washington, D.C.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
